Gastrointestinal cancer undergoing chemotherapy. Malignant neoplasm of ill-defined sites within the digestive system
Conditions
Interventions
Intervention 1: Intervention group: Participants will complete the Douleur Neuropathique questionnaire for neuropathic pain and the St. Mary's Hospital Sleep Questionnaire. Then they will be instruct
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: A known case of gastrointestinal cancer (stomach or colon) that is at stage 0 to 3 of the disease Inpatients undergoing treatment with injectable platinum-based chemotherapy drugs, such as oxaliplatin Age 18 to 65 years old A score of 4 or higher based on the Douleur Neuropathic questionnaire (DN4) Patient self-reporting no history of diseases where neuropathic pain is a symptom (e.g. diabetes) At least one month has passed since the start of injectable chemotherapy sessions
Exclusion criteria
Exclusion criteria: Presence of skin or bone lesions in the massage area
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Neuropathic pain. Timepoint: Before and after shiatsu massage. Method of measurement: Douleur Neuropathic Questioner.;Sleep quality. Timepoint: Before and after shiatsu massage. Method of measurement: St. Mary's Hospital Sleep Quality Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahla Qomi
Arak University of Medical Sciences
Outcome results
None listed